Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker – 4.0)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Commentaries and Discussions

Commentaries and Discussions

Commentaries are short articles which outline an observation on a published article. If a researcher wishes to comment on a paper published in Adv Clin Exp Med, before formal submission, they should contact the journal with a pre-submission enquiry: Managing Editor Marek Misiak: marek.misiak@umw.edu.pl [alternative e-mail for Chinese authors: marek.misiak@friend.pl]. If submission of a Commentary is approved, they will be then invited to publish a brief article, which will be bi-directionally linked to the original paper it discusses. A Commentary should consist of up to 1500 words, excluding references, and at most 2 tables or figures (2 tables and 2 figures at most in 1 paper). The number of references is not limited. A Commentary can have up to 2 authors. Commentaries should be written in a neutral tone, and must relate to the original published article. All such articles considered for publication will be subject to peer review, and the decision to accept or reject an article is at the editor’s discretion.

If the submission serves only to identify a vital error or mistake in the published paper, it will usually lead to the publication of a clarification statement (correction or retraction).

After the Commentary is accepted for publication, it is shared with the authors of the article commented upon, and they are invited to respond (Author’s Response to the Commentary). Such response – if submitted – is published together with the Commentary. Such a response should consist of up to 1500 words, excluding references, and at most 2 tables or figures (2 tables and 2 figures at most in 1 paper). The number of references is not limited.

This author’s response again may be subject to peer review and will be shared with the commentator, who may be invited to submit a Rejoinder. The rejoinder may be subject to peer review and shared with the authors of the published article. No further correspondence will be considered for publication. The editor may reject correspondence at any point before the comment, response and rejoinder are finalized.

Each paper in this sequence – Commentary, Author’s Response to the Commentary and Rejoinder – is published as soon it is accepted for publication. Therefore, they can appear as ahead of print papers and at the end of an issue few months apart from each other.